Information theoretical analysis of aging as a risk factor for heart disease

Aging and Disease

Volumn 6, Issue 3, 2015, Pages 196-207

  Blokh, David ^a   Stambler, Ilia ^a,b  

^a CD Technologies Ltd   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

Author keywords

Biomarkers of aging; Biomarkers of disease; In silicoassessment of anti aging interventions; Normalized mutual information; System aging

Indexed keywords

CHOLESTEROL; GLUCOSE; THALLIUM;

AGING; ALGORITHM; ANGINA PECTORIS; ARTICLE; BLOOD PRESSURE; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXERCISE; FLUOROSCOPY; HEART DISEASE; HEART RATE; HYPOTHESIS; MATHEMATICAL PARAMETERS; SEX; ST SEGMENT DEPRESSION; THEORETICAL STUDY; THORAX PAIN;

EID: 84935444957     PISSN: None     EISSN: 21525250     Source Type: Journal    
DOI: 10.14336/AD.2014.0623     Document Type: Article

References (44)

1. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. (2012). Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet, 380:2095-2128.
2. Chung HY, Cesari M, Anton S, Marzetti E, Giovannini S, Seo AY, et al. (2009). Molecular inflammation: Underpinnings of aging and age-related diseases. Ageing Res Rev, 8:18-30.
3. Lunn JS1, Sakowski SA, Hur J, Feldman EL (2011). Stem cell technology for neurodegenerative diseases. Ann Neurol, 70:353-361.
4. Baylis D, Bartlett DB, Patel HP, Roberts HC (2014). Understanding how we age: insights into inflammaging. Longev Healthspan, 3:6.
5. Dai DF, Chiao YA, Marcinek DJ, Szeto HH, Rabinovitch PS (2014). Mitochondrial oxidative stress in aging and healthspan. Longev Healthspan, 3:6.
6. Zieman S, Kass D (2004). Advanced glycation end product cross-linking: Pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail, 10:144-149.
7. World Health Organization. Ageing and Life Course. Accessed June 2014, Retrieved from: http://www.who.int/ageing/en/.
8. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, et al. (2012). A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010, Lancet, 380:2224-2260.
9. Jacobs JM, Cohen A, Ein-Mor E, Stessman J (2013). Cholesterol, statins, and longevity from age 70 to 90 years. J Am Med Dir Assoc, 14:883-888.
10. Petersen LK, Kaare Christensen K, Kragstrup J (2010). Lipid-lowering treatment to the end? A review of observational studies and RCTs on cholesterol and mortality in 80+-year olds. Age Ageing, 39:674-680.
11. Rae MJ, Butler RN, Campisi J, de Grey ADNJ, Finch CE, Gough M, et al. (2010). The demographic and biomedical case for late-life interventions in aging. Science Transl Med, 2 (40), 40cm21.
12. Meadows J, Danik JS, Albert MA (2007). Primary prevention of ischemic heart disease. In: Antman EM, editor. Cardiovascular Therapeutics: A Companion to Braunwald's Heart Disease. Third edition. Philadelphia PA: Saunders Elsevier, 178-220.
13. Yu R, Navab K, Navab M (2010). Near term prospects for ameliorating cardiovascular aging. In: Fahy GM, West MD, Coles LS, Harris SB, editors. The Future of Aging: Pathways to Human Life Extension. New York: Springer, 279-306.
14. Nicolis G, Prigogine I. Exploring Complexity. New York: W.H. Freeman, 1990.
15. Glass GV, Stanley JC. Statistical Methods in Education and Psychology. New Jersey: Prentice-Hall, 1970.
16. Renyi A (1959). On measures of dependence. Acta Math Acad Sci Hungar, 10:441-451.
17. Zvarova J, Studeny M (1997). Information theoretical approach to constitution and reduction of medical data. Int J Med Inform 45:65-74.
18. Cover TM, Thomas JA. Elements of Information Theory. Second edition. New York: Wiley-Interscience, 2006.
19. Conover WJ. Practical Nonparametric Statistics. New York: Wiley-Interscience, 1999.
20. Glantz SA. Primer of Biostatistics. Fourth edition. New York: McGraw-Hill, 1994.
21. UCI Machine Learning Repository. Heart Disease Data Set. Creators: Hungarian Institute of Cardiology. Budapest: Andras Janosi, M.D.; University Hospital, Zurich, Switzerland: William Steinbrunn, M.D.; University Hospital, Basel, Switzerland: Matthias Pfisterer, M.D.; V.A. Medical Center, Long Beach and Cleveland Clinic Foundation: Robert Detrano, M.D., Ph.D. Donor: David W. Aha. Accessed June 2014, Retrieved from: http://archive.ics.uci.edu/ml/datasets/Heart+Disease.
22. Zar JH. Biostatistical Analysis. Fifth edition. New Jersey: Prentice Hall, 2010.
23. Carter AJ, Nguyen AQ (2011). Antagonistic pleiotropy as a widespread mechanism for the maintenance of polymorphic disease alleles. BMC Med Genet, 12:160.
24. Le Couteur DG, Simpson SJ (2011). Adaptive senectitude: the prolongevity effects of aging. J Gerontol A Biol Sci Med Sci, 66:179-182.
25. Goto M (2008). Inflammaging (inflammation + aging): A driving force for human aging based on an evolutionarily antagonistic pleiotropy theory? Biosci Trends, 2:218-30.
26. Williams GC (1957). Pleiotropy, natural selection, and the evolution of senescence. Evolution, 11:398-411.
27. Rose MR. Evolutionary Biology of Aging. Oxford: Oxford University Press, 1991.
28. Kirkwood T. Time of Our Lives: The Science of Human Aging. Oxford: Oxford University Press, 1999.
29. Pocock SJ, McCormack V, Gueyffier F, Boutitie F, Fagard RH, Boissel JP (2001). A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. Br Med J, 323:75-81.
30. Wahman K, Nash MS, Lewis JE, Seiger A, Levi R (2010). Cardiovascular disease risk factors in persons with paraplegia: the Stockholm spinal cord injury study. J Rehabil Med, 42:272-278.
31. Ray KK, Seshasai SRK, Erqou S, Sever P, Jukema JW, Ford I, Sattar N (2010). Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants. Arch Intern Med, 170:1024-1031.
32. Milman S, Atzmon G, Crandall J, Barzilai N (2013). Phenotypes and genotypes of high density lipoprotein cholesterol in exceptional longevity. Curr Vasc Pharmacol [Epub ahead of print].
33. Baron AA, Baron SB (2007). High levels of HDL cholesterol do not predict protection from cardiovascular disease in women. Prev Cardiol, 10:125-127.
34. Foulley JL, Quaas RL (1995). Heterogeneous variances in Gaussian linear mixed models. Genet Sel Evol, 27:211-228.
35. Horvath S (2013). DNA methylation age of human tissues and cell types. Genome Biol, 14:R115.
36. Blokh D, Stambler I, Afrimzon E, Shafran Y, Korech E, Sandbank J, et al. (2007). The information-theory analysis of Michaelis-Menten constants for detection of breast cancer. Cancer Detect Prev, 31:489-498.
37. Blokh D, Zurgil N, Stambler I, Afrimzon E, Shafran Y, Korech E, et al. (2008). An information-theoretical model for breast cancer detection. Methods Inf Med, 47:322-327.
38. Blokh D, Stambler I, Afrimzon E, Platkov M, Shafran Y, Korech E, et al. (2009). Comparative analysis of cell parameter groups for breast cancer detection. Comput Methods Programs Biomed, 94:239-249.
39. Wu SS, Wang W, Annis DH (2008). On identification of the number of best treatments using the Newman-Keuls Test. Biometr J, 50:861-869.
40. Blokh D and Stambler I (2014). Estimation of heterogeneity in diagnostic parameters of age-related diseases. Aging Disease, 5 [Epub ahead of print].
41. Blokh D (2013). Information-theory analysis of cell characteristics in breast cancer patients. Int J Bioinform Biosci, 3:1-5.
42. Krutko VN, Dontsov VI, Smirnova TM (2005). Theories, methods and algorithms for diagnosing aging. ISA RAS Proceed, 13:105-143 (Russian).
43. Goldman DP, Cutler D, Rowe JW, Michaud PC, Sullivan J, Peneva D, Olshansky SJ (2013). Substantial health and economic returns from delayed aging may warrant a new focus for medical research. Health Aff, 10:1698-1705.
44. Stambler I (2014). The unexpected outcomes of antiaging, rejuvenation and life extension studies: an origin of modern therapies. Rejuvenation Res, 17 [Epub ahead of print].